Fundies.
English

Segment disclosures

Company overview

PHATHOM PHARMACEUTICALS, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 12 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment Aggregation Before Other Operating Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-09-30217297000 USD20261029Open filing evidence
2026-01-01 – 2026-06-30132575000 USD20260730Open filing evidence
2026-01-01 – 2026-03-3158301000 USD20260430Open filing evidence
2025-01-01 – 2025-12-31175110000 USD20260226Open filing evidence
2025-01-01 – 2025-09-30117526000 USD20261029Open filing evidence
2025-01-01 – 2025-06-3068023000 USD20260730Open filing evidence
2025-01-01 – 2025-03-3128519000 USD20260430Open filing evidence
2024-01-01 – 2024-12-3155252000 USD20260226Open filing evidence
2024-01-01 – 2024-09-3025588000 USD20251030Open filing evidence
2024-01-01 – 2024-06-309236000 USD20250807Open filing evidence
2024-01-01 – 2024-03-311912000 USD20250501Open filing evidence
2023-01-01 – 2023-12-31682000 USD20250306Open filing evidence